These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 27170385)
21. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806 [TBL] [Abstract][Full Text] [Related]
22. Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease. Liberal R; Grant CR; Longhi MS; Mieli-Vergani G; Vergani D IUBMB Life; 2015 Feb; 67(2):88-97. PubMed ID: 25850692 [TBL] [Abstract][Full Text] [Related]
23. Implications of gut microbiota in autoimmune liver diseases. Qian Q; He W; Tang R; Ma X Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160 [TBL] [Abstract][Full Text] [Related]
24. [Immune-mediated liver diseases]. Pár A Orv Hetil; 2007 Apr; 148 Suppl 1():35-8. PubMed ID: 17430792 [TBL] [Abstract][Full Text] [Related]
25. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Mattner J Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858 [TBL] [Abstract][Full Text] [Related]
26. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Terjung B; Spengler U Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618 [TBL] [Abstract][Full Text] [Related]
27. Autoimmune diseases of the liver. Manns MP Clin Lab Med; 1992 Mar; 12(1):25-40. PubMed ID: 1563239 [TBL] [Abstract][Full Text] [Related]
28. HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Cassinotti A; Birindelli S; Clerici M; Trabattoni D; Lazzaroni M; Ardizzone S; Colombo R; Rossi E; Porro GB Am J Gastroenterol; 2009 Jan; 104(1):195-217; quiz 194, 218. PubMed ID: 19098870 [TBL] [Abstract][Full Text] [Related]
29. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study. Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337 [TBL] [Abstract][Full Text] [Related]
30. Causal effect of autoimmune liver diseases on cancer: Meta-analyses of cohort studies and Mendelian randomization study. Gu D; Zhang M; Wang Y; Bai Y; Wang X; Deng G Liver Int; 2022 Oct; 42(10):2216-2226. PubMed ID: 35775855 [TBL] [Abstract][Full Text] [Related]
31. Shared genetic risk factors in autoimmune liver disease. Czaja AJ; Santrach PJ; Breanndan Moore S Dig Dis Sci; 2001 Jan; 46(1):140-7. PubMed ID: 11270778 [TBL] [Abstract][Full Text] [Related]
32. Clinical analysis of liver transplantation in autoimmune liver diseases. Zhong CP; Xi ZF; Xia Q Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100 [TBL] [Abstract][Full Text] [Related]
34. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis. Schramm C; Lohse AW Clin Rev Allergy Immunol; 2005 Apr; 28(2):105-14. PubMed ID: 15879617 [TBL] [Abstract][Full Text] [Related]
35. Two decades of research on autoimmune liver disease in Turkey. Demir N; Ekin N; Torgutalp M; Wahlin S; Efe C Turk J Gastroenterol; 2020 Dec; 31(12):877-882. PubMed ID: 33626000 [TBL] [Abstract][Full Text] [Related]
37. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis. Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168 [TBL] [Abstract][Full Text] [Related]
38. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Cargill T; Culver EL Front Immunol; 2021; 12():661196. PubMed ID: 33936097 [TBL] [Abstract][Full Text] [Related]